317 related articles for article (PubMed ID: 2843317)
1. Treatment of nontuberculous mycobacterial infections in pediatric patients.
Levin RH; Bolinger AM
Clin Pharm; 1988 Jul; 7(7):545-51. PubMed ID: 2843317
[TBL] [Abstract][Full Text] [Related]
2. [Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Rev Mal Respir; 1989; 6(4):335-42. PubMed ID: 2552547
[TBL] [Abstract][Full Text] [Related]
3. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
Hoy J; Mijch A; Sandland M; Grayson L; Lucas R; Dwyer B
J Infect Dis; 1990 Apr; 161(4):801-5. PubMed ID: 2156947
[TBL] [Abstract][Full Text] [Related]
4. Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes.
Dautzenberg B; Truffot C; Mignon A; Rozenbaum W; Katlama C; Perronne C; Parrot R; Grosset J
Tubercle; 1991 Sep; 72(3):168-75. PubMed ID: 1663282
[TBL] [Abstract][Full Text] [Related]
5. Progress report: prophylaxis and therapy for MAC.
Currier J
AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
Tsukamura M; Yamori S
Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003
[TBL] [Abstract][Full Text] [Related]
7. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
[TBL] [Abstract][Full Text] [Related]
8. Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDS.
Dautzenberg B; Olliaro P; Ruf B; Esposito R; Opravil M; Hoy JF; Rozenbaum W; Carosi GP; Micoud M; L'Age M; Pirotta N; Sassella D
Clin Infect Dis; 1996 Apr; 22(4):705-8. PubMed ID: 8729209
[TBL] [Abstract][Full Text] [Related]
9. [Mycobacterium avium complex infection: a growing problem in our country].
Blázquez R; Ruiz-Serrano MJ; Muñoz P; Miralles P; Pérez-Tascón M; Bouza E
Rev Clin Esp; 1997 Mar; 197(3):158-62. PubMed ID: 9273579
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
Tomioka H; Saito H
Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
[TBL] [Abstract][Full Text] [Related]
14. [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections].
Kawahara S; Nagare H
Kekkaku; 1998 Feb; 73(2):77-82. PubMed ID: 9545700
[TBL] [Abstract][Full Text] [Related]
15. Disseminated MAC: current treatment strategies.
Ferreira T
STEP Perspect; 1995; 7(2):15-6. PubMed ID: 11362719
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with rifabutin in the treatment of mycobacterial infections.
De Cian W; Sassella D; Wynne BA
Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin.
Benson CA; Kessler HA; Pottage JC; Trenholme GM
Arch Intern Med; 1991 Mar; 151(3):582-5. PubMed ID: 2001140
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.
Sullam PM; Gordin FM; Wynne BA
Clin Infect Dis; 1994 Jul; 19(1):84-6. PubMed ID: 7948562
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
Pulido F; Iribarren JA; Kindelan JM; Moreno S
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
[TBL] [Abstract][Full Text] [Related]
20. MAC management.
PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
